Simplex Trading’s Co-Diagnostics CODX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-33
Closed -$168 9211
2025
Q4
$168 Buy
+33
New +$359 ﹤0.01% 8266
2025
Q1
Sell
-1,400
Closed -$31K 8644
2024
Q4
$31K Buy
1,400
+1,327
+1,818% +$41.9K ﹤0.01% 6313
2024
Q3
$2K Sell
73
-20
-22% -$768 ﹤0.01% 7966
2024
Q2
$3K Buy
+93
New +$3.38K ﹤0.01% 8088
2023
Q2
Sell
-117
Closed -$5K 9089
2023
Q1
$5K Sell
117
-2,186
-95% -$175K ﹤0.01% 8014
2022
Q4
$174K Sell
2,303
-4
-0.2% -$375 ﹤0.01% 4389
2022
Q3
$222K Sell
2,307
-546
-19% -$76.4K ﹤0.01% 4473
2022
Q2
$480K Sell
2,853
-250
-8% -$38K ﹤0.01% 3487
2022
Q1
$575K Sell
3,103
-160
-5% -$33.1K ﹤0.01% 3659
2021
Q4
$874K Sell
3,263
-664
-17% -$174K ﹤0.01% 3050
2021
Q3
$978K Buy
3,927
+154
+4% +$44.9K ﹤0.01% 3102
2021
Q2
$933K Buy
3,773
+3,738
+10,680% +$961K ﹤0.01% 3225
2021
Q1
$989K Buy
+35
New +$14K ﹤0.01% 2404
2020
Q4
Sell
-25
Closed -$1.02M 8416
2020
Q3
$1.02M Buy
25
+8
+47% +$4.11K ﹤0.01% 2211
2020
Q2
$1M Buy
17
+6
+55% +$2.74K ﹤0.01% 2148
2020
Q1
$261K Buy
+11
New +$1.91K ﹤0.01% 3280

Other funds holding CODX

Simplex Trading's CODX Position: Q1 2026 in Review

Simplex Trading sold out of Co-Diagnostics (CODX) in Q1 2026, closing a stake of 325 shares — an estimated $1.64K sold.

Simplex Trading first reported a position in CODX in Q1 2020 and held it in 20 quarters. The position peaked at $328K in Q2 2020. 14 funds tracked by Wall St. Rank hold CODX as of Q1 2026.

  • Simplex Trading reported no remaining Co-Diagnostics position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 325 Co-Diagnostics shares in Q1 2026, an estimated $1.64K.
  • Simplex Trading first reported a position in Co-Diagnostics in Q1 2020 and held it in 20 quarters.
  • Simplex Trading's Co-Diagnostics position peaked at $328K in Q2 2020.
  • 14 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.